Search Our Scientific Publications & Authors

Int J Cardiol 2022 Aug 6. Epub 2022 Aug 6.

Department of Internal Medicine and Cardiology, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Augustenburgerplatz 1, 13353 Berlin, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Germany; Berlin Institute of Health (BIH), Berlin, Germany.

Background: In patients with de novo acute heart failure (AHF) requiring veno-arterial extracorporeal membrane oxygenation (VA-ECMO), endomyocardial biopsy (EMB) has been recently shown to be feasible and a helpful method to clarify differential diagnoses, including acute myocarditis. This study aimed to evaluate the feasibility and safety of EMB in patients with a left ventricular (LV) implanted Impella® device.

Methods And Results: This retrospective, single-center study involves 22 cardiogenic shock patients [SCAI shock stage: C (91%)] requiring mechanical circulatory support (MCS) either by Impella® axial pumps [20 patients (91%)] alone or in combination with VA-ECMO [2 patients (9%)] between December 2017 and January 2022. Read More

Intensive Care Med 2022 Aug 9. Epub 2022 Aug 9.

PhyMedExp, University of Montpellier, Institut National de La Santé Et de La Recherche Médicale (INSERM), Centre National de La Recherche Scientifique (CNRS), Centre Hospitalier Universitaire (CHU) Montpellier, Montpellier, France.

Extracorporeal carbon dioxide removal (ECCOR) is a form of extracorporeal life support (ECLS) largely aimed at removing carbon dioxide in patients with acute hypoxemic or acute hypercapnic respiratory failure, so as to minimize respiratory acidosis, allowing more lung protective ventilatory settings which should decrease ventilator-induced lung injury. ECCOR is increasingly being used despite the lack of high-quality evidence, while complications associated with the technique remain an issue of concern. This review explains the physiological basis underlying the use of ECCOR, reviews the evidence regarding indications and contraindications, patient management and complications, and addresses organizational and ethical considerations. Read More

ASAIO J 2022 Jan 19. Epub 2022 Jan 19.

Section of Palliative Medicine, Department of Medicine, MedStar Washington Hospital Center, Washington, DC.

Best practices for left ventricular assist devices (LVADs) deactivation at end-of-life (EOL) have yet to be elucidated. We conducted a single-institution retrospective review of patients who died following LVAD deactivation between January 2017 and March 2020. Data were obtained from institutional databases and electronic health record and were analyzed using descriptive statistics. Read More

Arch Iran Med 2022 Jun 1;25(6):383-393. Epub 2022 Jun 1.

Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Background: COVID-19, with its high transmission and mortality rates and unknown outcomes, has become a major concern in the world. Among people with COVID-19, severe cases can quickly progress to serious complications, and even death. So, the present study aimed to examine the relationship between the severity of the disease and the outcome in patients afflicted by COVID-19 during hospitalization. Read More

Plast Reconstr Surg 2022 Aug 4. Epub 2022 Aug 4.

Division of Oral and Maxillofacial Surgery, Department of Dentistry, Chang Gung Memorial Hospital at Taipei, Taipei, Taiwan.

Summary: Dental implant placement complications in patients with symphysis cross-arch defect occur following single-barrel fibula mandible reconstruction due to mechanical stress of the implant. The authors compared surgical complications and implant outcomes for patients following single-barrel fibula mandible reconstruction with immediate implant placement or following completion of vertical distraction osteogenesis. Read More